Bio Protocol announces the launch of PEPTAI, with a total supply of 20% allocated to BIO stakers
BlockBeats News, May 14th, the DeSci protocol Bio Protocol announced that the PEPTAI token has officially launched on the Base chain, simultaneously initiating the autonomous AI agent for peptide drug discovery. Users can directly claim the token in the Bio App, and BIO token stakers (veBIO holders) can receive 20% of the total supply with a 6-month linear release. At TGE, 20% can be redeemed, and claiming the entire amount before the full release will penalize the unreleased portion.
According to data, PEPTAI's market value surged to over $15 million within 5 minutes of its launch, currently standing at $13.5 million with a trading volume of $2.2 million.
BlockBeats reminds users that the prices of related tokens are highly volatile, so investment should be approached with caution.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bristol-Myers Squibb (BMY.US) rises in pre-market trading! Two experimental drugs report positive results in Phase 3 clinical trials, diversifying and accelerating the pipeline
Bristol Myers Squibb's two experimental drugs, used to treat a rare endocrine cancer and a deadly lung disease, have achieved success in Phase III clinical trials, injecting momentum into the pharmaceutical company’s new product pipeline.
BUZZ-Enovix shares rise on preliminary revenue growth in the third quarter
Citius Pharma CEO Mazur presents at ThinkEquity Conference
Crypto prices
More
